Always verify pricing and state availability on the provider's website before signing up.How our reviews work →

Amble vs Curex

An in-depth comparison of two leading GLP-1 Providers

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

7.4

Amble

Best for mainstream telehealth GLP-1 access
★★★3.7

Starting at $179/mo

CompoundedSemaglutideTirzepatide
Visit Amble
7.8

Curex

Best for affordable compounded GLP-1 with strong corporate transparency and pharmacy testing
★★★3.9

Starting at $149/mo

Compounded SemaglutideCompounded TirzepatideOral Dissolving TabletsLegitScript Verified
Visit Curex

Side-by-Side Comparison

FeatureAmbleCurex
Overall Score7.4/107.8/10
Starting Price$179/mo$149/mo
Editorial Rating3.7 ★ /53.9 ★ /5
Features3 features4 features
States Available5045
Compounded✓ Yes✓ Yes
Brand Name
FSA/HSA Accepted
FDA WarningsNoneNone

Pros & Cons

Amble

Pros

  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access

Cons

  • Limited public information on program details

Curex

Pros

  • LegitScript certified
  • Named entity (Curex, Inc.) with two offices — Miami FL and NYC
  • Competitive pricing: semaglutide $149/mo, tirzepatide $199/mo
  • No membership fee ever
  • Injectable and oral dissolving tablet formats
  • Third-party lab testing via FDA/DEA certified labs
  • Works with LabCorp and Quest Diagnostics
  • 43+ state coverage with transparent exclusion list

Cons

  • Not available in AK, AR, CT, HI, MA, NM, MO
  • Compounded only — explicitly states 'We don't prescribe Ozempic, Wegovy, Zepbound, or Mounjaro'
  • Primary business is allergy immunotherapy — GLP-1 is a newer vertical

Our Verdict

Winner: CurexScore: 7.8/10

Curex edges out Amble with a higher overall score of 7.8/10 and is particularly strong for affordable compounded GLP-1 with strong corporate transparency and pharmacy testing. Amble remains a solid alternative, especially if you're looking for mainstream telehealth GLP-1 access.

Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.